March 5, 2014
ESMA Issues New Opinion on Complex Product Sales Practice
Summary: ESMA’s recently published opinion on MiFID practices for firms selling complex products focuses on ensuring that firms take appropriate measures to protect investors from additional risks. The opinion defines what ESMA considers to be a complex product and discusses aspects of compliance—internal controls, product suitability and appropriateness assessments, related disclosures and communications, and sales monitoring—to which firms should give enhanced attention.